Literature DB >> 19322589

Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.

Maria R Wing1, Julie Ziegler, Carl D Langefeld, Maggie C Y Ng, Steven M Haffner, Jill M Norris, Mark O Goodarzi, Donald W Bowden.   

Abstract

Multiple studies have identified FTO gene variants associated with measures of adiposity in European-derived populations. The objective of the study was to determine whether FTO variants were associated with adiposity, including visceral and subcutaneous adipose tissue (VAT, SAT), and glucose homeostasis measures in the Insulin Resistance Atherosclerosis Family Study (IRASFS). A total of 27 SNPs in FTO intron 1, including SNPs prominent in the literature (rs9939609, rs8050136, rs1121980, rs17817449, rs1421085, and rs3751812), were genotyped in 1,424 Hispanic Americans and 604 African Americans. Multiple SNPs were associated with BMI and SAT (P values ranging from 0.001 to 0.033), and trending or associated with waist circumference (P values ranging from 0.008 to 0.099) in the Hispanic Americans. No association was observed with VAT, illustrating that FTO variants are associated with overall fat mass instead of specific fat depots. For the glucose homeostasis measures, variants were associated with fasting insulin but, consistent with other studies, after BMI adjustment, no evidence of association remained. The lack of association of FTO SNPs with insulin sensitivity is consistent with the lack of association with VAT, since these traits are strongly correlated. In the African Americans, only rs8050136 and rs9939609 were associated with BMI and WAIST (P values of 0.011 and 0.034), and associated or trending towards association with SAT (P values of 0.038 and 0.058). These results confirm that FTO variants are associated with adiposity measures, predisposing individuals to obesity by increasing overall fat mass in Hispanic Americans and to a lesser degree in African Americans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322589      PMCID: PMC2792578          DOI: 10.1007/s00439-009-0656-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  44 in total

1.  Association of the FTO gene with BMI.

Authors:  Steven C Hunt; Steven Stone; Yuanpei Xin; Christina A Scherer; Charles L Magness; Shawn P Iadonato; Paul N Hopkins; Ted D Adams
Journal:  Obesity (Silver Spring)       Date:  2008-01-24       Impact factor: 5.002

2.  FTO polymorphisms in oceanic populations.

Authors:  Jun Ohashi; Izumi Naka; Ryosuke Kimura; Kazumi Natsuhara; Taro Yamauchi; Takuro Furusawa; Minato Nakazawa; Yuji Ataka; Jintana Patarapotikul; Pornlada Nuchnoi; Katsushi Tokunaga; Takafumi Ishida; Tsukasa Inaoka; Yasuhiro Matsumura; Ryutaro Ohtsuka
Journal:  J Hum Genet       Date:  2007-10-11       Impact factor: 3.172

3.  Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population.

Authors:  M Horikoshi; K Hara; C Ito; N Shojima; R Nagai; K Ueki; P Froguel; T Kadowaki
Journal:  Diabetologia       Date:  2007-10-10       Impact factor: 10.122

4.  The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain.

Authors:  Robert Fredriksson; Maria Hägglund; Pawel K Olszewski; Olga Stephansson; Josefin A Jacobsson; Agnieszka M Olszewska; Allen S Levine; Jonas Lindblom; Helgi B Schiöth
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

5.  Regulation of Fto/Ftm gene expression in mice and humans.

Authors:  George Stratigopoulos; Stephanie L Padilla; Charles A LeDuc; Elizabeth Watson; Andrew T Hattersley; Mark I McCarthy; Lori M Zeltser; Wendy K Chung; Rudolph L Leibel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-06       Impact factor: 3.619

6.  Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.

Authors:  Nicholette D Palmer; Mark O Goodarzi; Carl D Langefeld; Julie Ziegler; Jill M Norris; Steven M Haffner; Michael Bryer-Ash; Richard N Bergman; Lynne E Wagenknecht; Kent D Taylor; Jerome I Rotter; Donald W Bowden
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

7.  Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.

Authors:  Laura Pascoe; Andrea Tura; Sheila K Patel; Ibrahim M Ibrahim; Ele Ferrannini; Eleftheria Zeggini; Michael N Weedon; Andrea Mari; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling; Mark Walker
Journal:  Diabetes       Date:  2007-09-05       Impact factor: 9.461

8.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.

Authors:  Salam A Al-Attar; Rebecca L Pollex; Matthew R Ban; T Kue Young; Peter Bjerregaard; Sonia S Anand; Salim Yusuf; Bernard Zinman; Stewart B Harris; Anthony Jg Hanley; Philip W Connelly; Murray W Huff; Robert A Hegele
Journal:  Cardiovasc Diabetol       Date:  2008-03-13       Impact factor: 9.951

10.  The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.

Authors:  Thomas Gerken; Christophe A Girard; Yi-Chun Loraine Tung; Celia J Webby; Vladimir Saudek; Kirsty S Hewitson; Giles S H Yeo; Michael A McDonough; Sharon Cunliffe; Luke A McNeill; Juris Galvanovskis; Patrik Rorsman; Peter Robins; Xavier Prieur; Anthony P Coll; Marcella Ma; Zorica Jovanovic; I Sadaf Farooqi; Barbara Sedgwick; Inês Barroso; Tomas Lindahl; Chris P Ponting; Frances M Ashcroft; Stephen O'Rahilly; Christopher J Schofield
Journal:  Science       Date:  2007-11-08       Impact factor: 47.728

View more
  49 in total

1.  Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis.

Authors:  Haina Wang; Shuqian Dong; Hui Xu; Jun Qian; Jingyun Yang
Journal:  Mol Biol Rep       Date:  2011-12-22       Impact factor: 2.316

2.  Fine mapping of the association with obesity at the FTO locus in African-derived populations.

Authors:  Mohamed T Hassanein; Helen N Lyon; Thutrang T Nguyen; Ermeg L Akylbekova; Kevin Waters; Guillaume Lettre; Bamidele Tayo; Terrence Forrester; Daniel F Sarpong; Dan O Stram; Johannah L Butler; Rainford Wilks; Jiankang Liu; Loic Le Marchand; Laurence N Kolonel; Xiaofeng Zhu; Brian Henderson; Richard Cooper; Colin McKenzie; Herman A Taylor; Christopher A Haiman; Joel N Hirschhorn
Journal:  Hum Mol Genet       Date:  2010-04-29       Impact factor: 6.150

3.  Exploring differences in adiposity in two U.S. Hispanic populations of Mexican origin using social, behavioral, physiologic and genetic markers: the IRAS Family Study.

Authors:  Kendra A Young; Tasha E Fingerlin; Carl D Langefeld; Carlos Lorenzo; Steven M Haffner; Lynne E Wagenknecht; Jill M Norris
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

4.  Affective response to physical activity as an intermediate phenotype.

Authors:  Harold H Lee; Jessica A Emerson; Lauren Connell Bohlen; David M Williams
Journal:  Soc Sci Med       Date:  2018-11-10       Impact factor: 4.634

5.  Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.

Authors:  Emily S Wan; Michael H Cho; Nadia Boutaoui; Barbara J Klanderman; Jody S Sylvia; John P Ziniti; Sungho Won; Christoph Lange; Sreekumar G Pillai; Wayne H Anderson; Xiangyang Kong; David A Lomas; Per S Bakke; Amund Gulsvik; Elizabeth A Regan; James R Murphy; Barry J Make; James D Crapo; Emiel F Wouters; Bartolome R Celli; Edwin K Silverman; Dawn L DeMeo
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-29       Impact factor: 6.914

6.  Implication of European-derived adiposity loci in African Americans.

Authors:  J M Hester; M R Wing; J Li; N D Palmer; J Xu; P J Hicks; B H Roh; J M Norris; L E Wagenknecht; C D Langefeld; B I Freedman; D W Bowden; M C Y Ng
Journal:  Int J Obes (Lond)       Date:  2011-07-12       Impact factor: 5.095

7.  FTO polymorphisms moderate the association of food reinforcement with energy intake.

Authors:  Jennifer L Scheid; Katelyn A Carr; Henry Lin; Kelly D Fletcher; Lara Sucheston; Prashant K Singh; Robbert Salis; Richard W Erbe; Myles S Faith; David B Allison; Leonard H Epstein
Journal:  Physiol Behav       Date:  2014-04-24

8.  Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk.

Authors:  Patrícia Amorim da Cunha; Lia Kubelka de Carlos Back; Aline Fernanda Rodrigues Sereia; Clara Kubelka; Maria Cecíia Menks Ribeiro; Bráulio Leal Fernandes; Ilíada Rainha de Souza
Journal:  Mol Biol Rep       Date:  2013-10-04       Impact factor: 2.316

9.  Moderate to vigorous physical activity interactions with genetic variants and body mass index in a large US ethnically diverse cohort.

Authors:  A S Richardson; K E North; M Graff; K M Young; K L Mohlke; L A Lange; E M Lange; K M Harris; P Gordon-Larsen
Journal:  Pediatr Obes       Date:  2013-03-25       Impact factor: 4.000

10.  Prevalence of loss-of-function FTO mutations in lean and obese individuals.

Authors:  David Meyre; Karine Proulx; Hiroko Kawagoe-Takaki; Vincent Vatin; Ruth Gutiérrez-Aguilar; Debbie Lyon; Marcella Ma; Helene Choquet; Fritz Horber; Wim Van Hul; Luc Van Gaal; Beverley Balkau; Sophie Visvikis-Siest; François Pattou; I Sadaf Farooqi; Vladimir Saudek; Stephen O'Rahilly; Philippe Froguel; Barbara Sedgwick; Giles S H Yeo
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.